reports
- Felix Fischer
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Si Yong Ng
Johnson & Johnson: 1 director
A director at Johnson & Johnson sold 100,000 shares at 221.229USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Zoetis Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 15 December 2025 in which we reassessed the appropriateness of the ratings in the context of th...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Rising Yields a Problem?; Russell 2000 Breakout We maintain our near-term bullish outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we flipped to neutral. Our intermediate-term bullish outlook has been in place since our 5/14/25 Compass. We will stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ continue to hold. We will maintain our bullish intermediate-term v...
RY. ROYAL BANK OF CANADA
LYG.. LLOYDS BANKING GROUP PLC ADS
BNS. BANK OF NOVA SCOTIA
BCS BARCLAYS PLC ADS
RIO RIO TINTO LIMITED
CENX CENTURY ALUMINUM COMPANY
BANK OTKRITIE FINANCIAL CORPORATION PJSC
AA ALCOA CORPORATION
NOHA NORSK HYDRO ASA ADS
XLV SELECT SECTOR SPDR-HEALTH CARE
NWG NATWEST GROUP
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
New Lockout Rally Underway? We had a near-term bullish outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ) from 4/22/25 to 11/19/25. After being near-term neutral for a week, we flipped back to bullish in our 11/25/25 Compass last week, all while maintaining our intermediate-term bullish outlook (as of our 5/14/25 Compass). We will stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ continue to hold. We will maintain our bullish intermediate-term view...
ZEUS OLYMPIC STEEL INC.
TMST TIMKENSTEEL CORP
STLD STEEL DYNAMICS INC.
RYI RYERSON HOLDING CORPORATION
CMC COMMERCIAL METALS COMPANY
KALU KAISER ALUMINUM CORPORATION
IWM ISHARES RUSSELL 2000 INDEX FUND
RTP.. RIO TINTO PLC ADS (MEXICO)
XLK SELECT SECTOR SPDR-TECHNOLOGY
SMH MARKET VECTORS SMEICONDOUCTOR ETF
KBE SPDR KBW BANK ETF
QQQ INVESCO QQQ TRUST
SMSMY SERIES 1
ELA SIMS METAL MANAGEMENT LTD. ADS
ENTERGY LA LLC DEB 5.875%41
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Coasting as We Stalk for Buying Opportunity; Downgrading Discretionary to Underweight We had been near-term bullish on the S&P 500 (SPX) since our 4/22/25 Compass, however, we are officially downgrading our near-term outlook to neutral. The SPX, Nasdaq 100 (QQQ), and Russell 2000 (IWM) are breaking below their 50-day MAs and are also violating their multi-month uptrends, signaling a consolidation period is here. With that said, our intermediate-term outlook remains bullish (as of our 5/14/25 Co...
- Dave Nicoski
- Ross LaDuke
Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Expecting a Rally Through Early-2026 We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the S&P 500 (SPX) is above 6028-6059. Additionally, we discussed since our 10/14/25 Compass how our near-term bullish outlook remains intact as long as the SPX holds above 6550-6569, which coincided with the 3-month upt...
- Dave Nicoski
- Ross LaDuke
Vermilion Macro Vision: Sector Synopsis
STRATEGY We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the S&P 500 (SPX) is above 6028-6059. Additionally, we discussed since our 10/14/25 Compass how our near-term bullish outlook remains intact as long as the SPX holds above 6550-6569, which coincided with the 3-month uptrend. SPX is now back at all...
Moody's Ratings says J&J's Ortho separation will modestly reduce scale...
Moody's Ratings (Moody's) said that on 14 October, Johnson & Johnson ("J&J") announced that it intends to separate its Orthopaedics business into an independent company called DePuy Synthes. The separation of the Orthopaedics business, which is part of J&J's medical devices segment ("MedTech") will ...
- Dave Nicoski
- Ross LaDuke
Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Russell 2000 Breaking Out to All-Time Highs We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). The S&P 500 (SPX) is trading within a well-defined 4-month uptrend that began in late-May. We will maintain our bullish outlook as long as market dynamics remain healthy and the SPX is above 6028-6059. We would need to see a break below 6450-6480 in order to have confidence that a consolidation period has finall...
Moody's Ratings assigns A3 rating to Zoetis' sr. notes; stable outlook
Moody's Ratings (Moody's) assigned an A3 rating to the new senior unsecured notes issuance of Zoetis Inc. (Zoetis). At the same time, we assigned a (P)A3 rating to Zoetis' senior unsecured shelf registration. There are no changes to Zoetis' other ratings including the A3 senior unsecured rating or t...
- Dave Nicoski
- Ross LaDuke
Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Nasdaq 100 and S&P 500 Breaking Out to All-Time Highs We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). Our near-term bullish outlook will remain in place as long as the S&P 500 (SPX), Nasdaq 100 (QQQ), and Russell 2000 (IWM) are above their 20-day MAs. We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the SPX is above 5700-5785. Short-term support on SP...
- Dave Nicoski
- Ross LaDuke
Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Local Bottom With Potential to be a Major Bottom Since late-February (2/25/25 Compass) we were expecting an 8-10% pullback to provide a buying opportunity. All that changed as of our 3/31/25 ETF Pathfinder, when we downgraded our outlook to bearish/cautious, citing several concerning developments. It all led us to believe a break below 5500 and the potential for a prolonged downturn was increasingly likely. A historic selloff ensued. We did get positive trade news and some accommodative comment...
XLP SELECT SECTOR SPDR-CONSUMER STAPLES
XLF SELECT SECTOR SPDR-FINANCIAL
XLK SELECT SECTOR SPDR-TECHNOLOGY
XLRE REAL ESTATE SPDR
XLU SELECT SECTOR SPDR-UTILITIES
XLC THE COMMUNICATION SERVICES SELECT SECTOR SPDR FUND
XLB. ISHARES CORE CANADIAN LONG TER
XLY AUXLY CANNABIS GROUP INC
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Johnson & Johnson and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 2 April 2025 in which we reassessed the appropriateness of the ratings in the context of ...
Moody's Ratings says J&J's talc overhang remains after court ruling, b...
Moody's Ratings (Moody's) said that Johnson & Johnson's ("J&J") talc overhang remains after its latest talc subsidiary bankruptcy attempt was denied in courts, but its strong business profile and financial flexibility mitigate ongoing litigation pressures. There is no change at this time to J&J's ra...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Near-Term Downside Likely Following False Breakouts Our long-term outlook remains bullish as long as the S&P 500 remains above 5770-5850 and 5600-5670 (worst case), and we are buyers at these levels. With that said, we see potential for near-term downside as the S&P 500, Nasdaq 100 (QQQ), and FANG+ (FNGS) (1) could not decisively break out to new highs, (2) display bearish false breakouts, (3) have fallen back into their 2+ month trading ranges, (4) are violating their 1+ month uptrends, and (5...
LLY ELI LILLY AND COMPANY
CFSL COCA-COLA FEMSA SAB DE CV (ADR)
JNJ JOHNSON & JOHNSON
BMY BRISTOL-MYERS SQUIBB COMPANY
AKOB EMBOTELLADORA ANDINA S.A. SERIES B ADS
FMX FOMENTO ECONOMICO MEXICANO S.A.B. DE C.V. ADS
BMTA BRITISH AMERICAN TOBACCO PLC ADS
PM PHILIP MORRIS INTERNATIONAL INC.
ABBV ABBVIE INC.
CCHGY COCA-COLA HBC AG
ABT ABBOTT LABORATORIES
AZN ASTRAZENECA PLC ADS
GSK. GLAXOSMITHKLINE PLC CEDEAR
IMBBY IMPERIAL BRANDS PLC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.